Cutaneous herpes simplex virus infections

Am Fam Physician. 1991 May;43(5):1655-64.

Abstract

Affecting millions of Americans each year, herpes simplex virus infections are among the most common human viral infections. Many clinical forms exist, depending on the site of infection and the patient's age and immune status. Clinical evaluation and laboratory studies help establish the diagnosis. Acyclovir is the drug most often used to treat herpes simplex virus infections, although newer agents, such as phosphonoformate trisodium, may be required for acyclovir-resistant infections.

Publication types

  • Review

MeSH terms

  • Acyclovir / administration & dosage
  • Acyclovir / adverse effects
  • Acyclovir / therapeutic use*
  • Administration, Oral
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Diagnosis, Differential
  • Drug Resistance, Microbial
  • Foscarnet
  • Herpes Simplex / diagnosis
  • Herpes Simplex / drug therapy*
  • Herpes Simplex / pathology
  • Humans
  • Idoxuridine / administration & dosage
  • Idoxuridine / therapeutic use
  • Infusions, Intravenous
  • Phosphonoacetic Acid / administration & dosage
  • Phosphonoacetic Acid / analogs & derivatives
  • Phosphonoacetic Acid / therapeutic use
  • Recurrence
  • Skin Diseases, Infectious / diagnosis
  • Skin Diseases, Infectious / drug therapy*
  • Skin Diseases, Infectious / pathology
  • Trifluridine / administration & dosage
  • Trifluridine / therapeutic use
  • Vidarabine / administration & dosage
  • Vidarabine / therapeutic use

Substances

  • Antiviral Agents
  • Foscarnet
  • Vidarabine
  • Idoxuridine
  • Phosphonoacetic Acid
  • Trifluridine
  • Acyclovir